Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112245672 | 11224567 | 2 | F | 201003 | 20160627 | 20150629 | 20160704 | EXP | CA-AMGEN-CANSP2011040671 | AMGEN | 16.00 | YR | T | F | Y | 0.00000 | 20160704 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112245672 | 11224567 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, QWK | 103795 | 50 | MG | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | /wk | ||||||
| 112245672 | 11224567 | 2 | SS | ENBREL | ETANERCEPT | 1 | 103795 | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | |||||||||||
| 112245672 | 11224567 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 112245672 | 11224567 | 4 | SS | ORENCIA | ABATACEPT | 1 | Unknown | UNK | 0 | ||||||||||
| 112245672 | 11224567 | 5 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Unknown | UNK | 0 | ||||||||||
| 112245672 | 11224567 | 6 | SS | RITUXAN | RITUXIMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 112245672 | 11224567 | 7 | SS | ARTHROTEC | DICLOFENAC SODIUMMISOPROSTOL | 1 | Oral | 75 MG, QWK | 0 | 75 | MG | /wk | |||||||
| 112245672 | 11224567 | 8 | C | HUMIRA | ADALIMUMAB | 1 | UNK | 0 | |||||||||||
| 112245672 | 11224567 | 9 | C | METHOTREXATE. | METHOTREXATE | 1 | Oral | 25 MG, QWK | 0 | 25 | MG | /wk | |||||||
| 112245672 | 11224567 | 10 | C | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112245672 | 11224567 | 1 | Juvenile idiopathic arthritis |
| 112245672 | 11224567 | 2 | Rheumatoid arthritis |
| 112245672 | 11224567 | 3 | Product used for unknown indication |
| 112245672 | 11224567 | 4 | Product used for unknown indication |
| 112245672 | 11224567 | 5 | Product used for unknown indication |
| 112245672 | 11224567 | 6 | Product used for unknown indication |
| 112245672 | 11224567 | 7 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112245672 | 11224567 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112245672 | 11224567 | Drug ineffective | |
| 112245672 | 11224567 | Juvenile idiopathic arthritis | |
| 112245672 | 11224567 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112245672 | 11224567 | 1 | 20090903 | 201106 | 0 | |
| 112245672 | 11224567 | 9 | 2009 | 0 |